Prosecution Insights
Last updated: August 18, 2026

Examiner: SOROUSH, ALI

Tech Center 1600 • Art Units: 1611 1614 1616 1617

This examiner grants 47% of resolved cases

Performance Statistics

47.3%
Allow Rate
-12.7% vs TC avg
790
Total Applications
+30.3%
Interview Lift
1325
Avg Prosecution Days
Based on 783 resolved cases, 2023–2026

Rejection Statute Breakdown

2.1%
§101 Eligibility
17.8%
§102 Novelty
58.2%
§103 Obviousness
14.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18013174 THERAPEUTIC AGENT FOR DRUG-INDUCED BRADYCARDIA AND BRADYARRHYTHMIA Non-Final OA NISSAN CHEMICAL CORPORATION
18023594 COMPOSITIONS AND METHODS FOR TREATING AMYLOID-RELATED CONDITIONS Final Rejection The Regents of the University of California
18273708 Materials and Methods for Treating Viral and Other Medical Conditions Non-Final OA Biotronik AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month